CellSource Co

CellSource Co Tangible Book Value per Share

The Tangible Book Value per Share of CellSource Co (4880.T) as of Oct 27, 2026 is 300.58 JPY. In the previous year, Tangible Book Value per Share was 301.50 JPY — a change of -0.31% (lower).

Tangible Book Value per Share

300.58JPY

YoY

-0.31%

Last updated:

Tangible Book Value per Share of CellSource Co is 2025 300.58 JPY. Tangible Book Value per Share of CellSource Co was 2024 301.50 JPY. It decreases by -0.31% lower compared to the previous year.

The CellSource Co Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
20.01 JPY
Jan 1, 2019
80.86 JPY
Jan 1, 2020
102.73 JPY
Jan 1, 2021
136.62 JPY
Jan 1, 2022
190.37 JPY
Jan 1, 2023
311.76 JPY
Jan 1, 2024
301.50 JPY
Jan 1, 2025
300.58 JPY
The CellSource Co Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
300.58JPY-0.31%
301.50JPY-3.29%
311.76JPY+63.76%
190.37JPY+39.34%
136.62JPY+33.00%
102.73JPY+27.04%
80.86JPY+304.08%
20.01JPY+90.92%
10.48JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Tangible Book Value per Share of CellSource Co is 300.58 JPY in 2025.

Tangible Book Value per Share of CellSource Co changed from 301.50 JPY to 300.58 JPY, representing a -0.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — CellSource Co

All Key Metrics — CellSource Co